Targeting a key enzyme in the microorganism responsible for the disease could stop both its growth and ability to infect ...

(Reuters) -U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, ...

Lyme disease, the most common tick-borne illness in the U.S. and Europe, is caused by Borrelia burgdorferi. A new study may ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in ...

The study, published in the Journal of Veterinary Internal Medicine, examined the effects of paricalcitol -- a synthetic form ...

Tuberculosis, an ongoing pandemic, highlights and exacerbates global disparities. With the prevailing model of standardised treatment in vertical health programmes, it is unsurprising that ...

Frantz EyeCare’s highly-trained specialists strive to provide the most advanced treatment for healthy eyes in all phases of ...

Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a ...

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...

The Role of BbLDH in Borrelia burgdorferi Lyme disease, the most reported tick-borne illness in the United States and Europe, is primarily caused by the bacterium B. burgdorferi. One of the intriguing ...